Anti-viral drugs are medicines which are used specially for treating viral infections. Most anti-viral drugs are used for particular viral infections, similar to antibiotics, while a broad-spectrum anti-viral drug is effective against a varied range of viruses. Antiviral drugs do not kill their target pathogen, instead they inhibit the development of those viruses. The global anti-viral drugs market is projected to register a moderate growth rate in the pharmaceutical market and which is anticipated to increase due to rise in awareness level, increase in the diseased population and introduction of new drugs with improved efficacy. Some major patents are reaching their expiry during forecast period, such as for Combivir, Sustiva, Tenofovir, Tamiflu, Relenza and Telbivudine. The patent expiries of these blockbuster drugs is expected to trigger generic competition in the antivirals therapeutics market, which will make the market more competitive. The late stage pipeline drugs are expected to enter the market, which will positively impact the market. Most antivirals are considered comparatively harmless to host, and therefore are used to treat infections. They are different from viricides, which are not used for medication but can destroy or deactivate virus particles, either outside or inside the body. The anti-viral drugs are used in the treatment of patients suffering from herpes viruses, HIV, influenza A and B viruses and the hepatitis B and C viruses.

Anti-viral Drugs Market: Drivers and Restraints

As of October 2013, according to WHO, there were around 35.3 Mn people globally, infected with HIV. Therefore, increased viral infection incidences is one of the important factors that drives the anti-viral drugs market growth. Because of the solid R&D activities, newer and advanced treatments and formulations, such as vaccines, combination therapy and others, are being introduced in the market. Hence, strong R&D is one of the crucial factors in the anti-viral drugs market growth. On the other hand, high risk of failure, high cost of R&D and therapy, and government austerity are some of threats expected to hinder the growth of market. These are some factors anticipated to fuel growth of global anti-viral drugs market within the forecast period of 2016-2026. However, increasing usage of natural products and high cost of developing drugs are the key challenges faced by the market.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1951

Anti-viral Drugs Market: Segmentation

The global anti-viral drugs market is classified on the basis of product type, end user and geography.

Based on product type, the global anti-viral drugs market is segmented into the following:

Hepatitis-C antivirals

HIV antivirals

Herpes antivirals

Hepatitis-B antivirals

Influenza antivirals

Others (Pneumonia, Flu, etc.)

Based on end user, the global anti-viral drugs market is segmented into the following:

Hospitals

Clinics

Ambulatory Surgical Centers

Anti-viral Drugs Market: Overview

The generic market of anti-viral drugs is presently dominated by products such as didanosine, zidovudine, lamivudine and stavudine. The biggest driver of overall anti-viral drugs market is Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) therapeutic sales which accounted for more than half the share of the market 2010. At the end of 2012, 9.7 million people in low-income and middle-income countries were on antiretroviral treatment (ART). According to WHO, in 2012, number of patients on ART increased by 1.6 Mn, the largest increase in one year. Nearly four out of five people were freshly put on treatment in the sub-Saharan Africa. In 21 African countries with a high burden of HIV, two out of three people in need are receiving treatment, and two out of three positive pregnant women are receiving antiretroviral drugs to prevent HIV transmission to their infants.

Anti-viral Drugs Market: Regional Overview

Region wise, the global anti-viral drugs market is classified into regions namely, North America, Eastern Europe, Western Europe, Latin America, Japan, Asia-Pacific, Middle East and Africa. According to WHO, in countries with Major ART scale-up such as Brazil or China, the death rate among people living with HIV has decreased by 80%. In 2015, in India the number of people living with HIV were 2.1 Mn and in U.S. the number was around 1.2 Mn in the year 2013.

Request to View TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1951

Anti-viral Drugs Market: Key Players

Some of the key players in global anti-viral drugs market, which are focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, include Roche, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott, AstraZeneca, Cipla, Schering-Plough, Johnson & Johnson, Merck & Co and others.

Loading...

Comments

No comments to display.

Related posts

Geogrids Market Higher Mortality Rates by 2025

Geogrids are a class of geosynthetics which are composed of materials such as polyesters, high-density polyethylene and polypropylene, among others.

Global Digital Map Market Size is Registering CAGR of 12.7% from 2017 to 2023

The digital map market is projected to grow at a CAGR of 12.7% from 2017 to 2023. This is attributed to increase in the use of geospatial information and rise in use of smartphones.

Privacy Management Software Market Analysis, Share and Size, Trends, Industry Growth And Segment Forecasts To 2023

Privacy Management Software Market Research Report Information, —By Application (Compliance Management, Risk Management, Reporting and Analytics), Deployment Mode, Vertical (Telecommunication & IT, BFSI, Government & Defense) – Global Forecast till 2023 Market Synopsis The Global Privacy Management Software market is expected to grow at a significant CAGR during the forecast period The reports of identity theft, accidental disclosure of customer and proprietary business information as well as successful attempts by hackers to infiltrate systems and take information are on rise. The growing concern for data privacy has increased the number of laws and regulations that are concerned regarding the information to be collected and maintained. The process of storing the information - how and where, as well as transfer of the information is being scrutinized. Get Sample Report @ https://www.marketresearchfuture.com/sample_request/7400 Segmentation The global Privacy Management Software Market is segmented into application, deployment mode, organization size, vertical and region/country. By application, the global privacy management software is segmented into compliance management, risk management, reporting and analytics, and others. By deployment mode, the global privacy management software is segmented into on-premises and cloud. By organization size, the global privacy management software is segmented into small and medium-sized enterprises (SMEs) and large enterprises. Check Discount @ https://www.marketresearchfuture.com/check-discount/7400 Regional analysis The global market for privacy management software is expected to grow at a significant CAGR during the forecast period. The geographical analysis of privacy management software market is studied for North America, Europe, Asia-Pacific, and the rest of the world (including the Middle East, Africa, and Latin America). Key Players The key players in the privacy management software market are identified across all the major regions based on their country of origin, presence across different regions, recent key developments, product diversification, and industry expertise. Some of them are— Nymity Inc. (US), OneTrust, LLC (UK), TrustArc Inc (US), SIMBUS, LLC. (US), BigID, Inc. (US), International Business Machines Corporation (US), Protiviti Inc. (US), Proteus-Cyber Ltd. (UK), 2B Advice LLC (US), TokenEx (US), SureCloud (UK), AURA DIFUSION S.L.(US) Get More Information @ https://www.marketresearchfuture.com/press-release/privacy-management-software-market Intended Audience • Government Agencies • Privacy Management Software Service/Solution Providers • Financial Advisory/Consulting Firms • System Integrators • Research Institutes and Organizations • Technology Standards Organizations • Venture capitalist/angel investors • Information security directors/managers

Soil Stabilization Materials Market Is Expected To Register a CAGR of 6.6% during 2018-2028

Future Market Insights has announced the addition of the “Soil Stabilization Materials Market Global Industry Analysis 2018 - 2028 " report to their offering

Furfuryl Alcohol Market Approach A Value Worth US$ 1,493.7 Mn By The End Of 2028

Future Market Insights has announced the addition of the “Furfuryl Alcohol Market Global Industry Analysis 2018 - 2028 " report to their offering

High Abuse Shrink Bags Market Detailed Analytical Overview by 2027

High Abuse Shrink Bags Market: Global Industry Analysis and Opportunity Assessment 2017-2027

Plastic-Free Packs Market Registering a Strong Growth by 2027

Plastic-Free Packs Market: Global Industry Analysis and Opportunity Assessment 2017-2027